Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review

This evidence-based review addresses the question of whether testing for UGT1A1 mutations in patients with metastatic colorectal cancer treated with irinotecan leads to improvement in outcomes (e.g., irinotecan toxicity, response to treatment, morbidity, and mortality), when compared with no testing...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Palomaki, Glenn E., Bradley, Linda A., Douglas, Michael P., Kolor, Katherine, Dotson, W. David
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Medical Genetics 2009
Témata:
Evidence Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743611/
https://ncbi.nlm.nih.gov/pubmed/19125129
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky